Thus, IL-6 is a cytokine that affects the development of allodynia and hyperalgesia in a patient with IDD and, as a result, is a potential for analgesic therapy, which was confirmed using a selective inhibitor of IL-6 in the experiment. This evidence concerns the gene IL6 and intervertebral disk degenerative disorder.